Methenmadinone caproate

Methenmadinone caproate (MMC) is a synthetic progestin, a type of progestogen hormone. It is a derivative of methenmadinone and is used in hormonal contraception and hormone replacement therapy.

Chemical Structure and Properties[edit]

Methenmadinone caproate is a steroidal progestin. Its chemical structure is characterized by the presence of a caproate ester at the 17α position of the methenmadinone molecule. This modification enhances its lipophilicity, allowing for a longer duration of action when administered.

Pharmacology[edit]

Methenmadinone caproate acts by binding to the progesterone receptors in the body, mimicking the effects of natural progesterone. It exerts its effects by regulating the menstrual cycle, inhibiting ovulation, and altering the endometrium to prevent pregnancy.

Medical Uses[edit]

Methenmadinone caproate is primarily used in hormonal contraception and hormone replacement therapy. It is often administered in combination with estrogens to provide effective contraception and to manage symptoms of menopause.

Administration[edit]

Methenmadinone caproate is typically administered via intramuscular injection. The caproate ester allows for a slow release of the active hormone, providing sustained effects over a prolonged period.

Side Effects[edit]

Common side effects of methenmadinone caproate include nausea, headache, breast tenderness, and mood changes. Long-term use may be associated with an increased risk of thromboembolic events and breast cancer.

Related Pages[edit]

This medical article is a stub. You can help WikiMD by expanding the page.